| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 45 | 2022 | 452 | 8.760 |
Why?
|
| Hypoglycemic Agents | 23 | 2021 | 259 | 3.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 23 | 2022 | 689 | 3.430 |
Why?
|
| Medication Adherence | 23 | 2020 | 232 | 3.060 |
Why?
|
| Prediabetic State | 6 | 2019 | 62 | 2.310 |
Why?
|
| Humans | 138 | 2023 | 17622 | 2.260 |
Why?
|
| Postal Service | 7 | 2020 | 72 | 2.060 |
Why?
|
| Hypertension | 20 | 2019 | 486 | 2.030 |
Why?
|
| Cardiovascular Diseases | 14 | 2021 | 545 | 1.920 |
Why?
|
| Physician-Patient Relations | 15 | 2017 | 168 | 1.910 |
Why?
|
| Delivery of Health Care, Integrated | 7 | 2023 | 540 | 1.860 |
Why?
|
| Antihypertensive Agents | 15 | 2015 | 163 | 1.770 |
Why?
|
| Female | 95 | 2022 | 12715 | 1.740 |
Why?
|
| Telephone | 8 | 2017 | 159 | 1.730 |
Why?
|
| California | 46 | 2023 | 2433 | 1.700 |
Why?
|
| Patient Compliance | 11 | 2014 | 269 | 1.660 |
Why?
|
| Adult | 67 | 2023 | 7621 | 1.620 |
Why?
|
| Male | 81 | 2021 | 10014 | 1.600 |
Why?
|
| Blood Glucose | 9 | 2022 | 319 | 1.520 |
Why?
|
| Retrospective Studies | 32 | 2023 | 2502 | 1.520 |
Why?
|
| Aged | 62 | 2021 | 6223 | 1.510 |
Why?
|
| Pharmaceutical Services | 5 | 2019 | 36 | 1.490 |
Why?
|
| Health Promotion | 10 | 2017 | 293 | 1.410 |
Why?
|
| Middle Aged | 70 | 2021 | 7954 | 1.380 |
Why?
|
| Quality Improvement | 6 | 2017 | 189 | 1.220 |
Why?
|
| Delivery of Health Care | 6 | 2020 | 383 | 1.220 |
Why?
|
| United States | 41 | 2022 | 3922 | 1.200 |
Why?
|
| Glycated Hemoglobin A | 14 | 2022 | 179 | 1.190 |
Why?
|
| Health Maintenance Organizations | 16 | 2013 | 403 | 1.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 168 | 1.140 |
Why?
|
| Quality of Health Care | 10 | 2020 | 260 | 1.100 |
Why?
|
| Insurance, Pharmaceutical Services | 5 | 2014 | 23 | 1.100 |
Why?
|
| Aged, 80 and over | 22 | 2021 | 1976 | 1.020 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 208 | 0.980 |
Why?
|
| Mentoring | 2 | 2017 | 29 | 0.980 |
Why?
|
| Patient-Centered Care | 6 | 2016 | 190 | 0.980 |
Why?
|
| Primary Health Care | 14 | 2017 | 729 | 0.970 |
Why?
|
| Chronic Disease | 12 | 2010 | 398 | 0.940 |
Why?
|
| Practice Patterns, Physicians' | 10 | 2017 | 308 | 0.910 |
Why?
|
| Occupational Health Services | 2 | 2015 | 12 | 0.850 |
Why?
|
| Medicare Part D | 5 | 2010 | 15 | 0.850 |
Why?
|
| Cross-Sectional Studies | 19 | 2015 | 1295 | 0.810 |
Why?
|
| Medicare | 2 | 2015 | 197 | 0.810 |
Why?
|
| Health Services Research | 12 | 2019 | 201 | 0.790 |
Why?
|
| Adolescent | 21 | 2023 | 3625 | 0.780 |
Why?
|
| Risk Factors | 23 | 2021 | 3291 | 0.770 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 56 | 0.770 |
Why?
|
| Feeding and Eating Disorders | 1 | 2022 | 16 | 0.760 |
Why?
|
| Health Priorities | 3 | 2019 | 24 | 0.760 |
Why?
|
| Leadership | 2 | 2022 | 36 | 0.750 |
Why?
|
| Electronic Health Records | 10 | 2018 | 719 | 0.750 |
Why?
|
| Delayed Diagnosis | 2 | 2020 | 21 | 0.740 |
Why?
|
| Patient Satisfaction | 12 | 2017 | 193 | 0.740 |
Why?
|
| Comparative Effectiveness Research | 4 | 2015 | 59 | 0.740 |
Why?
|
| Program Evaluation | 7 | 2015 | 214 | 0.690 |
Why?
|
| Managed Care Programs | 6 | 2010 | 300 | 0.680 |
Why?
|
| Health Services Accessibility | 6 | 2022 | 269 | 0.680 |
Why?
|
| Logistic Models | 17 | 2019 | 866 | 0.680 |
Why?
|
| European Continental Ancestry Group | 5 | 2020 | 470 | 0.670 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2015 | 380 | 0.670 |
Why?
|
| Uterine Hemorrhage | 1 | 2020 | 9 | 0.660 |
Why?
|
| Pharmacy | 1 | 2020 | 12 | 0.650 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 37 | 0.650 |
Why?
|
| Outcome and Process Assessment (Health Care) | 7 | 2016 | 96 | 0.640 |
Why?
|
| Mental Disorders | 2 | 2020 | 276 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 120 | 0.630 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.610 |
Why?
|
| Physicians, Family | 6 | 2004 | 36 | 0.610 |
Why?
|
| Women's Health | 3 | 2022 | 198 | 0.610 |
Why?
|
| Health Services for the Aged | 1 | 2019 | 14 | 0.610 |
Why?
|
| Smoking Cessation | 2 | 2020 | 149 | 0.600 |
Why?
|
| Pandemics | 2 | 2020 | 295 | 0.590 |
Why?
|
| Quality Assurance, Health Care | 7 | 2010 | 120 | 0.580 |
Why?
|
| Quality Indicators, Health Care | 9 | 2017 | 124 | 0.570 |
Why?
|
| Glycemic Index | 1 | 2018 | 19 | 0.570 |
Why?
|
| Medicare Part C | 1 | 2018 | 11 | 0.570 |
Why?
|
| Research Personnel | 2 | 2015 | 28 | 0.560 |
Why?
|
| Cholesterol, LDL | 6 | 2017 | 117 | 0.550 |
Why?
|
| Outcome Assessment (Health Care) | 6 | 2016 | 213 | 0.540 |
Why?
|
| Weight Loss | 3 | 2017 | 298 | 0.540 |
Why?
|
| Asian Continental Ancestry Group | 2 | 2020 | 87 | 0.530 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2018 | 41 | 0.530 |
Why?
|
| Hyperlipidemias | 5 | 2011 | 44 | 0.530 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 84 | 0.520 |
Why?
|
| Insurance Coverage | 4 | 2010 | 99 | 0.520 |
Why?
|
| Incidence | 9 | 2022 | 1278 | 0.510 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2017 | 53 | 0.500 |
Why?
|
| Health Policy | 5 | 2017 | 106 | 0.500 |
Why?
|
| Comorbidity | 7 | 2019 | 552 | 0.500 |
Why?
|
| Drug Costs | 4 | 2013 | 32 | 0.500 |
Why?
|
| Blood Pressure | 11 | 2017 | 288 | 0.500 |
Why?
|
| Prescription Drugs | 2 | 2014 | 30 | 0.500 |
Why?
|
| Patient Participation | 3 | 2016 | 124 | 0.490 |
Why?
|
| Motivational Interviewing | 1 | 2016 | 36 | 0.490 |
Why?
|
| Health Care Surveys | 8 | 2017 | 210 | 0.470 |
Why?
|
| Mass Media | 1 | 2015 | 15 | 0.470 |
Why?
|
| Treatment Outcome | 12 | 2017 | 1161 | 0.470 |
Why?
|
| Depression | 5 | 2015 | 507 | 0.470 |
Why?
|
| Obesity | 4 | 2017 | 821 | 0.460 |
Why?
|
| Young Adult | 17 | 2021 | 2538 | 0.460 |
Why?
|
| Electronic Mail | 1 | 2015 | 51 | 0.450 |
Why?
|
| Total Quality Management | 2 | 2017 | 18 | 0.450 |
Why?
|
| Physicians, Women | 4 | 2009 | 10 | 0.440 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 559 | 0.440 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 402 | 0.430 |
Why?
|
| Translational Medical Research | 2 | 2015 | 32 | 0.430 |
Why?
|
| Contraception | 4 | 2018 | 23 | 0.420 |
Why?
|
| Esophageal Neoplasms | 3 | 2010 | 115 | 0.420 |
Why?
|
| Barrett Esophagus | 3 | 2010 | 114 | 0.410 |
Why?
|
| Insurance Claim Review | 6 | 2020 | 49 | 0.410 |
Why?
|
| Diabetes, Gestational | 4 | 2015 | 328 | 0.400 |
Why?
|
| Cohort Studies | 10 | 2020 | 2502 | 0.400 |
Why?
|
| Life Style | 6 | 2019 | 321 | 0.390 |
Why?
|
| Employee Incentive Plans | 1 | 2013 | 4 | 0.390 |
Why?
|
| Pharmacies | 2 | 2015 | 9 | 0.380 |
Why?
|
| Disease Management | 4 | 2006 | 110 | 0.370 |
Why?
|
| African Continental Ancestry Group | 1 | 2013 | 140 | 0.370 |
Why?
|
| Choice Behavior | 7 | 2016 | 45 | 0.360 |
Why?
|
| Health Behavior | 2 | 2013 | 348 | 0.360 |
Why?
|
| Family Planning Services | 3 | 2016 | 20 | 0.350 |
Why?
|
| Communication | 6 | 2016 | 181 | 0.350 |
Why?
|
| Self Care | 3 | 2007 | 144 | 0.350 |
Why?
|
| Patient Care Management | 2 | 2009 | 24 | 0.350 |
Why?
|
| Counseling | 4 | 2017 | 173 | 0.340 |
Why?
|
| Provider-Sponsored Organizations | 3 | 2005 | 3 | 0.330 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 64 | 0.330 |
Why?
|
| African Americans | 4 | 2020 | 429 | 0.330 |
Why?
|
| Diabetes Complications | 5 | 2021 | 103 | 0.320 |
Why?
|
| Systems Theory | 1 | 2010 | 2 | 0.320 |
Why?
|
| Race Relations | 1 | 2009 | 1 | 0.310 |
Why?
|
| Hawaii | 2 | 2020 | 62 | 0.310 |
Why?
|
| Community-Based Participatory Research | 1 | 2010 | 46 | 0.310 |
Why?
|
| Needs Assessment | 2 | 2020 | 66 | 0.310 |
Why?
|
| Multivariate Analysis | 10 | 2015 | 527 | 0.300 |
Why?
|
| Risk Reduction Behavior | 3 | 2015 | 102 | 0.300 |
Why?
|
| Treatment Refusal | 2 | 2008 | 30 | 0.290 |
Why?
|
| Registries | 5 | 2012 | 475 | 0.270 |
Why?
|
| Body Mass Index | 6 | 2017 | 959 | 0.270 |
Why?
|
| Adenocarcinoma | 2 | 2010 | 172 | 0.270 |
Why?
|
| Socioeconomic Factors | 5 | 2016 | 603 | 0.270 |
Why?
|
| Ethnic Groups | 5 | 2020 | 443 | 0.270 |
Why?
|
| Guideline Adherence | 2 | 2010 | 155 | 0.260 |
Why?
|
| Models, Statistical | 4 | 2018 | 171 | 0.260 |
Why?
|
| Contraception Behavior | 3 | 2016 | 16 | 0.260 |
Why?
|
| Accountable Care Organizations | 2 | 2017 | 5 | 0.260 |
Why?
|
| Pregnancy | 7 | 2018 | 1565 | 0.260 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 41 | 0.260 |
Why?
|
| Cost Sharing | 2 | 2018 | 28 | 0.250 |
Why?
|
| Gynecology | 3 | 2011 | 22 | 0.240 |
Why?
|
| Hispanic Americans | 3 | 2020 | 370 | 0.240 |
Why?
|
| Qualitative Research | 5 | 2019 | 290 | 0.240 |
Why?
|
| Professional-Patient Relations | 3 | 2016 | 48 | 0.240 |
Why?
|
| Odds Ratio | 5 | 2015 | 631 | 0.240 |
Why?
|
| Sex Factors | 5 | 2015 | 599 | 0.230 |
Why?
|
| Preventive Health Services | 2 | 2004 | 147 | 0.230 |
Why?
|
| Time Factors | 8 | 2021 | 1038 | 0.230 |
Why?
|
| Propensity Score | 2 | 2016 | 80 | 0.220 |
Why?
|
| Prevalence | 2 | 2020 | 830 | 0.220 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1157 | 0.220 |
Why?
|
| Monitoring, Physiologic | 2 | 2015 | 35 | 0.220 |
Why?
|
| Efficiency, Organizational | 3 | 2017 | 26 | 0.210 |
Why?
|
| Decision Making | 2 | 2017 | 177 | 0.210 |
Why?
|
| Gastroesophageal Reflux | 3 | 2009 | 77 | 0.210 |
Why?
|
| Reminder Systems | 1 | 2004 | 76 | 0.210 |
Why?
|
| Quality of Life | 3 | 2016 | 505 | 0.200 |
Why?
|
| Adiposity | 1 | 2014 | 71 | 0.200 |
Why?
|
| Patient Care Team | 4 | 2012 | 107 | 0.200 |
Why?
|
| Surveys and Questionnaires | 10 | 2016 | 1296 | 0.200 |
Why?
|
| Health Care Reform | 2 | 2015 | 20 | 0.190 |
Why?
|
| Risk | 2 | 2020 | 492 | 0.190 |
Why?
|
| Databases, Factual | 5 | 2015 | 304 | 0.190 |
Why?
|
| Housing | 1 | 2023 | 37 | 0.190 |
Why?
|
| Insulin | 3 | 2020 | 188 | 0.190 |
Why?
|
| Attitude to Health | 2 | 2004 | 147 | 0.190 |
Why?
|
| Algorithms | 2 | 2014 | 227 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2015 | 187 | 0.190 |
Why?
|
| Models, Organizational | 3 | 2013 | 54 | 0.190 |
Why?
|
| Dietary Fiber | 2 | 2010 | 60 | 0.180 |
Why?
|
| Hypolipidemic Agents | 4 | 2010 | 37 | 0.180 |
Why?
|
| Contraceptive Agents | 3 | 2018 | 6 | 0.180 |
Why?
|
| Group Practice | 4 | 2005 | 21 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 205 | 0.180 |
Why?
|
| Insulin, Short-Acting | 1 | 2021 | 3 | 0.180 |
Why?
|
| Precancerous Conditions | 2 | 2009 | 48 | 0.180 |
Why?
|
| Focus Groups | 2 | 2019 | 144 | 0.180 |
Why?
|
| Insulin, Long-Acting | 1 | 2021 | 12 | 0.180 |
Why?
|
| Independent Practice Associations | 4 | 2005 | 5 | 0.180 |
Why?
|
| Yoga | 1 | 2011 | 25 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2020 | 48 | 0.170 |
Why?
|
| Remote Consultation | 1 | 2020 | 9 | 0.170 |
Why?
|
| Fear | 1 | 2020 | 14 | 0.160 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 19 | 0.160 |
Why?
|
| Micronutrients | 1 | 2010 | 9 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 55 | 0.160 |
Why?
|
| Hypokalemia | 1 | 2020 | 1 | 0.160 |
Why?
|
| Diet | 2 | 2014 | 355 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 36 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 23 | 0.160 |
Why?
|
| Clinical Competence | 3 | 2010 | 108 | 0.160 |
Why?
|
| Hyperkalemia | 1 | 2020 | 15 | 0.160 |
Why?
|
| Patient Admission | 2 | 2019 | 69 | 0.160 |
Why?
|
| Insulin, Regular, Human | 1 | 2020 | 5 | 0.160 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2020 | 4 | 0.160 |
Why?
|
| Age Factors | 3 | 2018 | 874 | 0.160 |
Why?
|
| Heart Failure | 4 | 2020 | 414 | 0.150 |
Why?
|
| Syncope | 1 | 2019 | 11 | 0.150 |
Why?
|
| Drug Therapy | 2 | 2009 | 16 | 0.150 |
Why?
|
| Women | 1 | 1999 | 12 | 0.150 |
Why?
|
| Child | 2 | 2022 | 2485 | 0.150 |
Why?
|
| Social Work | 1 | 2019 | 16 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 1999 | 20 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2019 | 48 | 0.150 |
Why?
|
| Meat | 1 | 2009 | 27 | 0.150 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 88 | 0.150 |
Why?
|
| Motor Activity | 3 | 2015 | 207 | 0.140 |
Why?
|
| Hip Fractures | 1 | 2019 | 74 | 0.140 |
Why?
|
| Colorado | 2 | 2017 | 170 | 0.140 |
Why?
|
| Dietary Fats | 1 | 2009 | 89 | 0.140 |
Why?
|
| Hospitalization | 3 | 2022 | 831 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2018 | 84 | 0.140 |
Why?
|
| Physician's Role | 3 | 2017 | 26 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2013 | 214 | 0.140 |
Why?
|
| Pharmacists | 3 | 2014 | 50 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2016 | 368 | 0.130 |
Why?
|
| Spouses | 1 | 2017 | 9 | 0.130 |
Why?
|
| Work Performance | 1 | 2017 | 1 | 0.130 |
Why?
|
| Employee Performance Appraisal | 1 | 2017 | 5 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 55 | 0.130 |
Why?
|
| Social Support | 3 | 2019 | 215 | 0.130 |
Why?
|
| Disclosure | 1 | 2016 | 16 | 0.120 |
Why?
|
| Deductibles and Coinsurance | 2 | 2014 | 32 | 0.120 |
Why?
|
| Diabetic Neuropathies | 1 | 2016 | 10 | 0.120 |
Why?
|
| Office Visits | 1 | 2016 | 75 | 0.120 |
Why?
|
| Smoking | 1 | 2008 | 420 | 0.120 |
Why?
|
| Physicians, Primary Care | 1 | 2016 | 63 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 46 | 0.120 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 686 | 0.120 |
Why?
|
| Neoplasms | 1 | 2020 | 457 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 108 | 0.120 |
Why?
|
| Self Report | 2 | 2015 | 262 | 0.120 |
Why?
|
| Career Mobility | 1 | 2015 | 4 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2015 | 15 | 0.110 |
Why?
|
| Machine Learning | 1 | 2016 | 60 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 69 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 21 | 0.110 |
Why?
|
| Asian Americans | 2 | 2010 | 160 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2015 | 93 | 0.110 |
Why?
|
| Safety-net Providers | 1 | 2015 | 55 | 0.110 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 193 | 0.110 |
Why?
|
| Social Networking | 1 | 2014 | 20 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2015 | 119 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2015 | 125 | 0.110 |
Why?
|
| Social Environment | 1 | 2014 | 84 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 25 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2015 | 169 | 0.100 |
Why?
|
| Medicaid | 1 | 2015 | 188 | 0.100 |
Why?
|
| Health Systems Plans | 1 | 2013 | 3 | 0.100 |
Why?
|
| Physician Incentive Plans | 2 | 2004 | 4 | 0.100 |
Why?
|
| Vital Signs | 1 | 2013 | 12 | 0.100 |
Why?
|
| Blood Pressure Determination | 2 | 2011 | 56 | 0.100 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 11 | 0.100 |
Why?
|
| Trust | 3 | 2009 | 33 | 0.100 |
Why?
|
| Mass Screening | 2 | 2013 | 693 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2013 | 15 | 0.100 |
Why?
|
| Primary Prevention | 2 | 2012 | 61 | 0.100 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 204 | 0.100 |
Why?
|
| State Health Plans | 1 | 2013 | 32 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2010 | 87 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 46 | 0.100 |
Why?
|
| Obstetrics | 2 | 2011 | 20 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 32 | 0.090 |
Why?
|
| Drug Resistance | 1 | 2012 | 19 | 0.090 |
Why?
|
| Weight Gain | 1 | 2014 | 165 | 0.090 |
Why?
|
| Research Design | 4 | 2016 | 337 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 319 | 0.090 |
Why?
|
| Anxiety | 1 | 2012 | 162 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 145 | 0.090 |
Why?
|
| Health Care Costs | 4 | 2015 | 211 | 0.080 |
Why?
|
| Electronic Prescribing | 1 | 2010 | 7 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2012 | 186 | 0.080 |
Why?
|
| Cost Control | 1 | 2010 | 13 | 0.080 |
Why?
|
| Drugs, Generic | 1 | 2010 | 4 | 0.080 |
Why?
|
| Reimbursement, Incentive | 1 | 2010 | 21 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 144 | 0.080 |
Why?
|
| Fees, Pharmaceutical | 1 | 2009 | 2 | 0.080 |
Why?
|
| Language | 1 | 2010 | 52 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2010 | 33 | 0.080 |
Why?
|
| Reimbursement Mechanisms | 1 | 2009 | 17 | 0.080 |
Why?
|
| Research | 1 | 2010 | 60 | 0.080 |
Why?
|
| Causality | 1 | 2009 | 35 | 0.080 |
Why?
|
| Patients | 1 | 2009 | 30 | 0.080 |
Why?
|
| Specialization | 2 | 1999 | 21 | 0.070 |
Why?
|
| Observation | 1 | 2009 | 20 | 0.070 |
Why?
|
| Patient Care | 1 | 2009 | 30 | 0.070 |
Why?
|
| Diabetic Retinopathy | 2 | 2010 | 17 | 0.070 |
Why?
|
| Social Class | 1 | 2009 | 117 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2015 | 90 | 0.070 |
Why?
|
| Exercise | 1 | 2013 | 538 | 0.070 |
Why?
|
| Confounding Factors (Epidemiology) | 3 | 2014 | 82 | 0.070 |
Why?
|
| Peptic Ulcer | 2 | 1998 | 14 | 0.070 |
Why?
|
| Medical Audit | 1 | 2008 | 32 | 0.070 |
Why?
|
| Overweight | 2 | 2014 | 266 | 0.070 |
Why?
|
| Health Facility Administration | 1 | 2007 | 1 | 0.070 |
Why?
|
| Decision Making, Organizational | 1 | 2007 | 3 | 0.070 |
Why?
|
| Mammography | 2 | 2010 | 173 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 17 | 0.070 |
Why?
|
| Health Surveys | 1 | 2007 | 242 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 3 | 2014 | 80 | 0.060 |
Why?
|
| Ambulatory Care | 4 | 2010 | 228 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1107 | 0.060 |
Why?
|
| Practice Management, Medical | 1 | 2005 | 7 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 60 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 702 | 0.060 |
Why?
|
| Information Services | 1 | 2004 | 12 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 67 | 0.050 |
Why?
|
| Albuminuria | 2 | 2014 | 39 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 446 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2014 | 85 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 363 | 0.050 |
Why?
|
| Linear Models | 2 | 2017 | 204 | 0.050 |
Why?
|
| Clinical Protocols | 2 | 2016 | 39 | 0.050 |
Why?
|
| Information Systems | 1 | 2003 | 15 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2016 | 1251 | 0.050 |
Why?
|
| Medicine | 2 | 1999 | 17 | 0.050 |
Why?
|
| Interviews as Topic | 2 | 2008 | 324 | 0.050 |
Why?
|
| Benchmarking | 2 | 2017 | 34 | 0.050 |
Why?
|
| Women, Working | 1 | 2002 | 5 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2005 | 1093 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2004 | 294 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 12 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 16 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2011 | 107 | 0.040 |
Why?
|
| Fruit | 1 | 2010 | 79 | 0.040 |
Why?
|
| Potassium | 1 | 2020 | 14 | 0.040 |
Why?
|
| Vegetables | 1 | 2010 | 88 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2020 | 85 | 0.040 |
Why?
|
| Financing, Personal | 2 | 2010 | 18 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2020 | 125 | 0.040 |
Why?
|
| Economics, Medical | 1 | 1999 | 4 | 0.040 |
Why?
|
| Disease Progression | 1 | 2010 | 266 | 0.040 |
Why?
|
| Trans Fatty Acids | 1 | 2009 | 4 | 0.040 |
Why?
|
| Cooking | 1 | 2009 | 17 | 0.040 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 21 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2010 | 129 | 0.040 |
Why?
|
| Health Expenditures | 2 | 2010 | 72 | 0.040 |
Why?
|
| Geography | 1 | 2008 | 38 | 0.040 |
Why?
|
| Drug Prescriptions | 2 | 2010 | 143 | 0.030 |
Why?
|
| Helicobacter Infections | 1 | 1998 | 22 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 1998 | 24 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2008 | 228 | 0.030 |
Why?
|
| Animals | 1 | 2009 | 285 | 0.030 |
Why?
|
| Gastritis | 1 | 1997 | 2 | 0.030 |
Why?
|
| Dyspepsia | 1 | 1997 | 5 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 226 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 11 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 309 | 0.030 |
Why?
|
| Checklist | 1 | 2016 | 13 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 37 | 0.030 |
Why?
|
| Hospitals | 1 | 1997 | 71 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 1005 | 0.030 |
Why?
|
| San Francisco | 1 | 2016 | 62 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2004 | 268 | 0.030 |
Why?
|
| Automation | 1 | 2016 | 24 | 0.030 |
Why?
|
| Aging | 1 | 1997 | 159 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 1995 | 4 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 7 | 0.030 |
Why?
|
| Maternal Age | 1 | 1995 | 74 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 354 | 0.030 |
Why?
|
| Public Health | 1 | 2016 | 84 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 2015 | 3 | 0.030 |
Why?
|
| Tape Recording | 1 | 2014 | 5 | 0.030 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 11 | 0.030 |
Why?
|
| Biostatistics | 1 | 2014 | 11 | 0.030 |
Why?
|
| Selection Bias | 1 | 2014 | 16 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 70 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2017 | 256 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 46 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 65 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 171 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2014 | 20 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 22 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 104 | 0.030 |
Why?
|
| Data Collection | 2 | 2007 | 234 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 22 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 158 | 0.030 |
Why?
|
| Diffusion of Innovation | 2 | 2004 | 36 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2013 | 32 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2013 | 11 | 0.020 |
Why?
|
| Metformin | 1 | 2013 | 52 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2013 | 69 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 46 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 67 | 0.020 |
Why?
|
| Community Health Workers | 1 | 2012 | 13 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2014 | 129 | 0.020 |
Why?
|
| Diuretics | 1 | 2012 | 19 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 122 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 45 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 237 | 0.020 |
Why?
|
| Veterans | 1 | 2012 | 149 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 74 | 0.020 |
Why?
|
| Frustration | 1 | 2010 | 2 | 0.020 |
Why?
|
| Multilingualism | 1 | 2010 | 8 | 0.020 |
Why?
|
| Insurance, Medigap | 1 | 2009 | 1 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 92 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 302 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 21 | 0.020 |
Why?
|
| Asthma | 2 | 2003 | 401 | 0.020 |
Why?
|
| Physicians | 1 | 2010 | 120 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2010 | 283 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 135 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 67 | 0.020 |
Why?
|
| Empirical Research | 1 | 2005 | 1 | 0.010 |
Why?
|
| Financial Management | 1 | 2005 | 2 | 0.010 |
Why?
|
| Organizational Culture | 1 | 2005 | 17 | 0.010 |
Why?
|
| Learning | 1 | 2005 | 18 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2004 | 50 | 0.010 |
Why?
|
| Perception | 1 | 2003 | 56 | 0.010 |
Why?
|
| Case Management | 1 | 2002 | 29 | 0.010 |
Why?
|
| Medical Informatics | 1 | 2002 | 33 | 0.010 |
Why?
|
| England | 1 | 2002 | 3 | 0.010 |
Why?
|
| Efficiency | 1 | 2002 | 11 | 0.010 |
Why?
|
| Australia | 1 | 2002 | 26 | 0.010 |
Why?
|
| Canada | 1 | 2002 | 54 | 0.010 |
Why?
|
| Family Practice | 1 | 2002 | 41 | 0.010 |
Why?
|
| Workload | 1 | 2002 | 26 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2002 | 58 | 0.010 |
Why?
|
| Health Facility Environment | 1 | 1999 | 2 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 1999 | 85 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1998 | 65 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1999 | 161 | 0.010 |
Why?
|
| Quebec | 1 | 1995 | 2 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1995 | 18 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1995 | 15 | 0.010 |
Why?
|
| Parity | 1 | 1995 | 57 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 208 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 842 | 0.010 |
Why?
|